导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 63.83% | 13/1050 |
| 近一周 | -2.96% | 781/1104 |
| 近一月 | 2.26% | 29/1102 |
| 近一季 | -2.11% | 434/1092 |
| 近半年 | 35.61% | 46/1070 |
| 近一年 | 73.31% | 20/1018 |
| 近两年 | 330.03% | 4/926 |
| 近三年 | 194.00% | 25/833 |
| 成立以来 | 238.04% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
11.90% 33/1070 |
79.58% 111/1101 |
- - |
- - |
| 2025 | 74.83% 50/1065 |
-7.58% 996/1014 |
29.31% 3/1038 |
41.12% 176/1050 |
3.66% 210/1065 |
| 2024 | 8.94% 316/1011 |
-4.79% 558/960 |
-11.58% 907/983 |
9.69% 644/991 |
17.98% 25/1011 |
| 2023 | -31.98% 823/952 |
-5.78% 813/880 |
-11.35% 796/895 |
-11.56% 657/915 |
-7.93% 750/952 |
| 2022 | -5.82% 38/867 |
-23.84% 703/773 |
20.11% 21/806 |
2.31% 9/845 |
0.64% 418/867 |
| 2021 | 1.08% 344/740 |
0.50% 131/580 |
7.03% 428/659 |
-3.24% 297/704 |
-2.89% 538/740 |
| 2020 | 70.09% 145/554 |
-1.57% 201/419 |
41.36% 19/466 |
16.92% 109/517 |
4.56% 446/554 |
| 2019 | 60.14% 79/410 |
34.57% 156/1149 |
0.54% 281/1231 |
4.44% 211/390 |
13.34% 85/410 |
| 2018 | -23.72% 129/349 |
- - |
- - |
- - |
-11.10% 402/1080 |
| 2017 | 11.43% 127/285 |
- - |
- - |
- - |
- - |
| 2016 | -8.67% 65/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 新华策略精选股票 VS. 东吴新产业精选股票A(580008) |